Large genomic fibrillin-1 (FBN1) gene deletions provide evidence for true haploinsufficiency in Marfan syndrome
Authors:
- 10 May 2007
- journal article
- Published by Springer Nature in Human Genetics
- Vol. 122 (1) , 23-32
Abstract
Mutations in the FBN1 gene are the major cause of Marfan syndrome (MFS), an autosomal dominant connective tissue disorder, which displays variable manifestations in the cardiovascular, ocular, and skeletal systems. Current molecular genetic testing of FBN1 may miss mutations in the promoter region or in other noncoding sequences as well as partial or complete gene deletions and duplications. In this study, we tested for copy number variations by successively applying multiplex ligation-dependent probe amplification (MLPA) and the Affymetrix Human Mapping 500 K Array Set, which contains probes for ∼500,000 single-nucleotide polymorphisms (SNPs) across the genome. By analyzing genomic DNA of 101 unrelated individuals with MFS or related phenotypes in whom standard genetic testing detected no mutation, we identified FBN1 deletions in two patients with MFS. Our high-resolution approach narrowed down the deletion breakpoints. Subsequent sequencing of the junctional fragments revealed the deletion sizes of 26,887 and 302,580 bp, respectively. Surprisingly, both deletions affect the putative regulatory and promoter region of the FBN1 gene, strongly indicating that they abolish transcription of the deleted allele. This expectation of complete loss of function of one allele, i.e. true haploinsufficiency, was confirmed by transcript analyses. Our findings not only emphasize the importance of screening for large genomic rearrangements in comprehensive genetic testing of FBN1 but, importantly, also extend the molecular etiology of MFS by providing hitherto unreported evidence that true haploinsufficiency is sufficient to cause MFS.Keywords
This publication has 43 references indexed in Scilit:
- Fibrillin-1 regulates the bioavailability of TGFβ1Journal of Cell Biology, 2007
- Aneurysm Syndromes Caused by Mutations in the TGF-β ReceptorNew England Journal of Medicine, 2006
- FBN1, TGFBR1, and the Marfan‐craniosynostosis/mental retardation disorders revisitedAmerican Journal of Medical Genetics Part A, 2006
- The molecular genetics of Marfan syndrome and related disordersJournal of Medical Genetics, 2006
- Craniosynostosis and congenital heart anomalies associated with a maternal deletion of 15q15-22.1American Journal of Medical Genetics, 2003
- Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype?Human Molecular Genetics, 2003
- A nonsense mutation in the fibrillin-1 gene of a Marfan syndrome patient induces NMD and disrupts an exonic splicing enhancerGenes & Development, 2002
- Molecular analysis of eight mutations in FBN1Human Genetics, 1999
- Four Novel FBN1 Mutations: Significance for Mutant Transcript Level and EGF-like Domain Calcium Binding in the Pathogenesis of Marfan SyndromeGenomics, 1993
- Craniosynostosis in an infant with an interstitial deletion of 15q [46, XY,del(15)(q15q22.1)]American Journal of Medical Genetics, 1990